Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$25.45
-1.02-3.85%
Last update: Oct 6, 4:00 PM
$25.45
-1.02-3.85%
Neurogene Inc (NGNE) Stock Price, Quote, News & History
NGNENASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Neurogene (NASDAQ:NGNE) through any online brokerage.
Other companies in Neurogene’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Neurogene has a consensus price target of $59.55.
The stock price for Neurogene (NASDAQ: NGNE) is $25.45 last updated October 6, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Neurogene.
Neurogene does not have any upcoming earnings scheduled.
There is no upcoming split for Neurogene.
Neurogene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
